Patterson L - Search Results

1

Protein deregulation associated with breast cancer metastasis.

Chan KK, Matchett KB, McEnhill PM, Dakir el H, McMullin MF, El-Tanani Y, Patterson L, Faheem A, Rudland PS, McCarron PA, El-Tanani M. Chan KK, et al. Among authors: patterson l. Cytokine Growth Factor Rev. 2015 Aug;26(4):415-23. doi: 10.1016/j.cytogfr.2015.05.002. Epub 2015 May 31. Cytokine Growth Factor Rev. 2015. PMID: 26088937 Review.

2

Function and antagonism of beta3 integrins in the development of cancer therapy.

Sheldrake HM, Patterson LH. Sheldrake HM, et al. Among authors: patterson lh. Curr Cancer Drug Targets. 2009 Jun;9(4):519-40. doi: 10.2174/156800909788486713. Curr Cancer Drug Targets. 2009. PMID: 19519320 Review.

3

Targeting Hypoxic Prostate Tumors Using the Novel Hypoxia-Activated Prodrug OCT1002 Inhibits Expression of Genes Associated with Malignant Progression.

Nesbitt H, Byrne NM, Williams SN, Ming L, Worthington J, Errington RJ, Patterson LH, Smith PJ, McKeown SR, McKenna DJ. Nesbitt H, et al. Among authors: patterson lh. Clin Cancer Res. 2017 Apr 1;23(7):1797-1808. doi: 10.1158/1078-0432.CCR-16-1361. Epub 2016 Oct 3. Clin Cancer Res. 2017. PMID: 27697998

4

Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.

Sheldrake HM, Patterson LH. Sheldrake HM, et al. J Med Chem. 2014 Aug 14;57(15):6301-15. doi: 10.1021/jm5000547. Epub 2014 Mar 7. J Med Chem. 2014. PMID: 24568695 Review.

5

Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases.

Atkinson JM, Falconer RA, Edwards DR, Pennington CJ, Siller CS, Shnyder SD, Bibby MC, Patterson LH, Loadman PM, Gill JH. Atkinson JM, et al. Cancer Res. 2010 Sep 1;70(17):6902-12. doi: 10.1158/0008-5472.CAN-10-1440. Epub 2010 Jul 27. Cancer Res. 2010. PMID: 20663911 Free PMC article.

6

RGD-Binding Integrins in Prostate Cancer: Expression Patterns and Therapeutic Prospects against Bone Metastasis.

Sutherland M, Gordon A, Shnyder SD, Patterson LH, Sheldrake HM. Sutherland M, et al. Cancers (Basel). 2012 Oct 26;4(4):1106-45. doi: 10.3390/cancers4041106. Cancers (Basel). 2012. PMID: 24213501 Free PMC article.

7

Polysialyltransferase: a new target in metastatic cancer.

Falconer RA, Errington RJ, Shnyder SD, Smith PJ, Patterson LH. Falconer RA, et al. Among authors: patterson lh. Curr Cancer Drug Targets. 2012 Oct;12(8):925-39. doi: 10.2174/156800912803251225. Curr Cancer Drug Targets. 2012. PMID: 22463390 Review.

8

Nipple aspirate fluid-A liquid biopsy for diagnosing breast health.

Shaheed SU, Tait C, Kyriacou K, Mullarkey J, Burrill W, Patterson LH, Linforth R, Salhab M, Sutton CW. Shaheed SU, et al. Proteomics Clin Appl. 2017 Sep;11(9-10):1700015. doi: 10.1002/prca.201700015. Epub 2017 Jun 26. Proteomics Clin Appl. 2017. PMID: 28488344 Free PMC article. Clinical Trial.

9

An agarose spot chemotaxis assay for chemokine receptor antagonists.

Vinader V, Al-Saraireh Y, Wiggins HL, Rappoport JZ, Shnyder SD, Patterson LH, Afarinkia K. Vinader V, et al. Among authors: patterson lh. J Pharmacol Toxicol Methods. 2011 Nov-Dec;64(3):213-6. doi: 10.1016/j.vascn.2011.01.004. Epub 2011 Feb 1. J Pharmacol Toxicol Methods. 2011. PMID: 21292017

10

Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancer.

Presa D, Khurram SA, Zubir AZA, Smarakan S, Cooper PA, Morais GR, Sadiq M, Sutherland M, Loadman PM, McCaul J, Shnyder SD, Patterson LH, Pors K. Presa D, et al. Sci Rep. 2021 Sep 23;11(1):18930. doi: 10.1038/s41598-021-98217-z. Sci Rep. 2021. PMID: 34556703 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

764 results

Search Page